Comment on 'Semaglutide vs. liraglutide and incidence of diabetes and cardiovascular disease: A target trial emulation using real-world data'

Scritto il 10/10/2026
da Muhammad Adil Choudhry

No abstract

Br J Clin Pharmacol. 2026 Oct 9. doi: 10.1002/bcp.70882. Online ahead of print.

NO ABSTRACT

PMID:42855911 | DOI:10.1002/bcp.70882